Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

A recent study conducted by researchers from Seattle-based University of Washington and Durham, N.C.-based Duke University found a strong association between the use of fall-risk increasing drugs and ...

NerdWallet's list of the best high-yield savings accounts. Many, or all, of the products featured on this page are from our advertising partners who compensate us when you take certain actions on ...